Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02304458
Title Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

rhabdomyosarcoma

neuroblastoma

Advanced Solid Tumor

non-Hodgkin lymphoma

Hodgkin's lymphoma

medulloblastoma

osteosarcoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.